scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...863509D |
P356 | DOI | 10.1371/JOURNAL.PONE.0063509 |
P8608 | Fatcat ID | release_areg5rtybbazdnuzo4jtv7tl3q |
P932 | PMC publication ID | 3670872 |
P698 | PubMed publication ID | 23755107 |
P5875 | ResearchGate publication ID | 237098515 |
P50 | author | Christoph Flückiger | Q50646279 |
Aaron C Del Re | Q60705532 | ||
P2093 | author name string | Bruce E Wampold | |
Glen I Spielmans | |||
P2860 | cites work | Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 |
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials | Q24632255 | ||
Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials | Q28482475 | ||
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | Q29619093 | ||
Systematic review of the empirical evidence of study publication bias and outcome reporting bias | Q29619094 | ||
Adjustment for reporting bias in network meta-analysis of antidepressant trials | Q31100974 | ||
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis | Q34029684 | ||
The proof of the pudding: an illustration of the relative strengths of null hypothesis, meta-analysis, and Bayesian analysis | Q34044695 | ||
Statistical multiplicity in systematic reviews of anaesthesia interventions: a quantification and comparison between Cochrane and non-Cochrane reviews | Q34099242 | ||
Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
Hypothesis validity of clinical research | Q37939286 | ||
Escitalopram: superior to citalopram or a chiral chimera? | Q44686605 | ||
Ranking antidepressants. | Q53056709 | ||
Ranking antidepressants | Q57338302 | ||
Conducting Meta-Analyses in R with the metafor Package | Q58423162 | ||
P275 | copyright license | Creative Commons CC0 License | Q6938433 |
P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e63509 | |
P577 | publication date | 2013-06-03 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Efficacy of new generation antidepressants: differences seem illusory | |
P478 | volume | 8 |
Q94398502 | Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis |
Q94397745 | Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta‐analysis |
Q50791439 | Heightened risk of false positives in a network meta-analysis of social anxiety. |
Q24186842 | Immunosuppressive regimens for liver transplantation: a network meta-analysis |
Q50117601 | In pursuit of truth: A critical examination of meta-analyses of cognitive behavior therapy |
Q94400983 | Induction immunosuppression in adults undergoing liver transplantation: a network meta‐analysis |
Q30399628 | Interventions for hereditary haemochromatosis: an attempted network meta-analysis. |
Q90605764 | Is psychotherapy effective? A re-analysis of treatments for depression |
Q94400448 | Lifestyle modifications for non‐alcohol related fatty liver disease: a network meta‐analysis |
Q38737314 | Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. |
Q24186856 | Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysis |
Q34681207 | Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis. |
Q24186892 | Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysis |
Q38747707 | Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis. |
Q60628650 | Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder |
Q24200896 | Methods to decrease blood loss during liver resection |
Q24197525 | Methods to decrease blood loss during liver resection: a network meta-analysis |
Q38994915 | Methods to decrease blood loss during liver resection: a network meta-analysis. |
Q94400535 | Nutritional supplementation for non‐alcohol‐related fatty liver disease: a network meta‐analysis |
Q38891837 | Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis. |
Q90307931 | Pharmacological interventions for acute hepatitis C infection |
Q38912794 | Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis. |
Q24186882 | Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysis |
Q38736327 | Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. |
Q38867031 | Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. |
Q38738566 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. |
Q38833243 | Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. |
Q24186837 | Pharmacological treatments for acute hepatitis B infection: a network meta-analysis |
Q24186859 | Pharmacological treatments for acute hepatitis C infection: a network meta-analysis |
Q24186878 | Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis |
Q24186846 | Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis |
Q24186865 | Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysis |
Q24186852 | Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis |
Q24193305 | Pharmacological treatments for primary sclerosing cholangitis: a network meta-analysis |
Q89625832 | Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis |
Q94397632 | Primary prevention of bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis |
Q94398275 | Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis |
Q42674821 | The "spin" doctors |
Q93055502 | The dark side of the force: Multiplicity issues in network meta-analysis and how to address them |
Q33898415 | The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials |
Q94398603 | Treatment for ascites in people with decompensated liver cirrhosis: a network meta‐analysis |
Q94401268 | Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis |
Q94397703 | Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis |
Q24186874 | Treatments for hereditary haemochromatosis: a network meta-analysis |